When it was first launched in 2006, the Phenom™ desktop SEM caused a stir with its 30 second load time, superb image quality and easy to use touch screen user interface. Phenom-World has built on that success and have launched the second generation of desktop SEMs; the Phenom G2 Pro and the Phenom G2 Pure.
A tool for ensuring the consistency of biopharmaceutical glycosylation critical quality attributes (GCQAs).
Laser diffraction particle size analysis, already widely used in the characterization of a variety of OINDPs (orally inhaled and nasal drug products) is proving its value in the development of some of the newest drug delivery formulations – dry powder nasal sprays. This was the conclusion of a well-attended workshop on ‘Characterizing the Performance of Nasal Dry Powder Devices’ presented by Dr Paul Kippax, from Malvern Instruments, and Dr Julie Suman, President of NextBreath LLC, during May’s Respiratory Drug Delivery Europe 2011 (RDD 2011) conference in Berlin, Germany.
INFOTEHNA's Pharmaceutical Conference, biggest annual event of INFOTEHNA Group, happened from 25-27 May by the shore of the crystalline alpine lake Woerthersee on the outskirts of Klagenfurt, capital of the federal state of Carinthia in Austria. Combination of picturesque historical location and brand new modern Lindner Seepark Hotel provided perfect background setting for 3 days of workshops, presentations and meetings.
INFOTEHNA Group will be present at 17th EGA ANNUAL CONFERENCE titled "Generic Medicines Enhancing Pharmaceutical Competition and Ensuring Healthcare Sustainability", which will take place in Lisbon – Cascais, from 15 to 17 June. Preconference day will be dedicated to Pharmaceutical Patent Litigation Seminar: a Statistical and Practical Approach.
INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is proud to announce that it has recently completed its 300th QuickStart® Camp, which is a unique, week-long kick-off meeting with the customer that is designed to reconcile expectations and build study ownership by the entire project team right up front. QuickStart Camp is part of the second phase in INC Research's Trusted Process®, the company's proven, metrics-driven clinical trial outsourcing methodology. When compared to industry benchmarks established by CMR International Institute for Regulatory Science, customers experience 35 percent faster project startup time after experiencing QuickStart.
INC Research, LLC, a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, and Kendle International Inc. (Nasdaq: KNDL), today jointly announced a definitive merger agreement under which INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million. Kendle is a leading global CRO with extensive expertise in Phase I-IV clinical development and more than 3,000 associates in 31 countries worldwide.
INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, today announced the acquisition of Trident Clinical Research to expand its clinical trials outsourcing footprint and expertise in Australia, New Zealand and India. Under the terms of the agreement, Trident will become a wholly owned affiliate of INC Research and will operate as Trident Clinical Research, an INC Research company through its offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai. Trident’s operation in Mumbai will increase the reach of INC Research’s already sizeable clinical and data operations located in Gurgaon, India.
Alliance Life Sciences Consulting Group, a leading management and technology consultancy, delivered today a comprehensive recommendation of organizational and process enhancements to a midmarket pharmaceutical client for potentially more than $1 million annually in saved revenue leakage, while allowing the manufacturer to pursue new contracting strategies expected to deliver more than $12 million annually in increased revenue.
Key members of the Revenue Contract Management Practice at Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, will present “Implementation Readiness –How to Start on the Right Track,” focusing on preventing major risks that can disrupt Revenue Contract Management Implementations during iMANY Summit 2011, on Tuesday, May 24th at 2:40 p.m., at the Fontainebleau Miami Beach, Miami Beach, FL.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.